Page last updated: 2024-11-13

pladienolide b

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

pladienolide B: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID90909513
MeSH IDM0512905

Synonyms (1)

Synonym
pladienolide b

Research Excerpts

Overview

Pladienolide B is a potent cancer cell growth inhibitor that targets the SF3b1 subunit of the spliceosome. It is a 12-membered macrolide isolated from Streptomyces platensis Mer-11107.

ExcerptReferenceRelevance
"Pladienolide B (PB) is an mRNA splicing inhibitor and enhances ABA responses."( Chemical activation of Arabidopsis SnRK2.6 by pladienolide B.
Fujii, H; Mahfouz, MM; Punkkinen, M, 2021
)
1.6
"Pladienolide B is a potent cancer cell growth inhibitor that targets the SF3b1 subunit of the spliceosome. "( Inhibition of SF3b1 by pladienolide B evokes cycle arrest, apoptosis induction and p73 splicing in human cervical carcinoma cells.
Chen, Y; Di, C; Liu, Y; Qu, T; Wang, F; Wang, Y; Yan, J; Yang, H; Zhang, H; Zhang, Q; Zhang, X, 2019
)
2.27
"Pladienolide B (PB) is a potent cancer cell growth inhibitor that targets the SF3B1 subunit of the spliceosome. "( Coherence between cellular responses and in vitro splicing inhibition for the anti-tumor drug pladienolide B and its analogs.
Adams, MS; Anderson, DD; Bray, WM; Effenberger, KA; Ghosh, AK; Jurica, MS; Ma, N; Prichard, BE, 2014
)
2.06
"Pladienolide B is a 12-membered macrolide isolated from Streptomyces platensis Mer-11107. "( Stereochemistry of pladienolide B.
Asai, N; Fukuda, Y; Kotake, Y; Niijima, J; Sakai, T; Uehara, T, 2007
)
2.11
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (46)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's10 (21.74)29.6817
2010's26 (56.52)24.3611
2020's10 (21.74)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.17

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.17 (24.57)
Research Supply Index3.85 (2.92)
Research Growth Index4.85 (4.65)
Search Engine Demand Index47.46 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (36.17)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (8.70%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other42 (91.30%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]